10 completed, 6 unknown. 4 Phase 1, 4 Phase 2, 3 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Unknown 2 |
| Phase 2 | 4 | Completed 4 |
| Not applicable | 3 | Unknown 2, Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Erling Bjerregaard Pedersen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Sodium Nitrite on Renal Function and Blood Pressure in Hypertensive Versus Healthy Subjects Sodium nitrite, Sodium chloride - Hypertension | Phase 1 | Unknown | Erling Bjerregaard Pedersen | 30 | 2015-05-01 | 2015-08-19 |
| The Effect of Acyl-Ghrelin on Kidney Function and Blood Pressure in Healthy Volunteers Acyl-Ghrelin - Renal Tubular Transport | Phase 1 | Unknown | Erling Bjerregaard Pedersen | 15 | 2015-05-01 | 2015-08-19 |
| Central and Peripheral Blood Pressure in Treatment of Obstructive Sleep Apnea. CPAP - Hypertension, Obstructive Sleep Apnea | Not applicable | Unknown | Erling Bjerregaard Pedersen | 20 | 2014-02-01 | 2015-02-02 |
| Nocturnal Blood Pressure and Hypertension - Central and Peripheral 24-h Blood Pressure. Hypertension, Chronic Kidneys Disease | Unknown | Erling Bjerregaard Pedersen | 150 | 2014-01-01 | 2014-10-09 | |
| Central and Peripheral 24-h Blood Pressure Before and After 3 Month of CPAP Treatment in Obstructive Sleep Apnea CPAP - continuous airway pressure - Chronic Kidney Disease, Obstructive Sleep Apnea | Not applicable | Unknown | Erling Bjerregaard Pedersen | 30 | 2013-12-01 | 2014-10-09 |
| Nocturnal Blood Pressure - Central and Peripheral 24-h Blood Pressure in Chronic Kidney Disease. Chronic Kidney Disease, Obstructive Sleep Apnea | Unknown | Erling Bjerregaard Pedersen | 225 | 2013-10-01 | 2014-10-09 | |
| The Effect of Sodium Nitrite on Renal Function and Blood Pressure in Healthy Humans. A Dose-response Study Sodium nitrite, 40 micrograms/kg/hour, Sodium nitrite, 120 micrograms/kg/hour, Sodium nitrite, 240 micrograms/kg/hour - Healthy | Phase 1 | Completed | Erling Bjerregaard Pedersen | 12 | 2013-09-01 | 2014-10-09 |
| The Effects of Nebivolol on the NO-system in Patients With Essential Hypertension Nebivolol, placebo - Essential Hypertension | Phase 2 | Completed | Erling Bjerregaard Pedersen | 25 | 2012-08-01 | 2014-03-04 |
| Comparison of Telemedical and Conventional Treatment of Hypertension Telemedical home blood pressure measurements, Conventional blood pressure monitoring - Hypertension | Not applicable | Completed | Erling Bjerregaard Pedersen | 375 | 2011-03-01 | 2015-08-24 |
| Prevalence of Hypertension Using Telemedical Home Blood Pressure Measurements Telemedical home blood pressure measurements - Hypertension | Completed | Erling Bjerregaard Pedersen | 3159 | 2011-02-01 | 2015-02-04 | |
| The Effect of Amiloride and Spironolactone in Patients With Hypertension Spironolactone, Amiloride, Placebo - Hypertension | Phase 4 | Completed | Erling Bjerregaard Pedersen | 23 | 2010-09-01 | 2012-03-28 |
| Reno- and Vascular Protective Effect of a Vitamin-D-analogue in Moderate to Severe Chronic Kidney Disease Zemplar, Placebo - Chronic Kidney Disease | Phase 2 | Completed | Erling Bjerregaard Pedersen | 30 | 2010-07-01 | 2012-01-25 |
| The Effects of Atorvastatin on the Nitrogen Oxide-system in Patients With Type 2 Diabetes and Nephropathy Atorvastatin, Unikalk - Nephropathy, Cardiovascular Diseases | Phase 2 | Completed | Erling Bjerregaard Pedersen | 25 | 2010-05-01 | 2015-08-21 |
| The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic Nephropathy Atorvastatin, Unikalk - Nephropathy, Cardiovascular Diseases | Phase 2 | Completed | Erling Bjerregaard Pedersen | 25 | 2010-05-01 | 2015-08-21 |
| The Effects of Potassium on Physiological and Cardiovascular Variables in Healthy Persons Calcium, Potassium - Hypertension | Phase 1 | Completed | Erling Bjerregaard Pedersen | 25 | 2008-11-01 | 2015-08-21 |
| Urinary Concentration and Diluting Ability in Patients With Chronic Renal Disease and/ or Hypertension Renal Insufficiency, Chronic, Hypertension | Completed | Erling Bjerregaard Pedersen | 50 | 2004-05-01 | 2015-08-21 |
Hypertension (8) · Renal Insufficiency, Chronic (4) · Sleep Apnea, Obstructive (4) · Kidney Diseases (3) · Cardiovascular Diseases (2) · Diabetes Mellitus (1) · Essential Hypertension (1) · Proteinuria (1)
Atorvastatin (2) · Sodium Chloride (2) · Sodium Nitrite (2) · Amiloride (1) · Calcium (1) · Continuous Positive Airway Pressure (1) · Nebivolol (1) · Potassium (1) · Spironolactone (1) · acyl-ghrelin (1) · paricalcitol (1)
Denmark (14)
Nikolai Hoffmann-Petersen, MD (2) · Erling B Pedersen (1) · Erling B Pedersen, MD (1) · Erling B Pedersen, MD, DMSc (1) · Erling B Pedersen, Prof, MSci (1) · Erling B Pedersen, Professor (1) · Frank H Christensen, MD (1) · Frank H Mose, MD (1) · Jesper N Bech, MD, PhD (1) · Solveig K Matthesen, Cand.Med (1)
PMID 38018702, PMID 20923561, PMID 22149452, PMID 23889806, PMID 24256611, PMID 26208671, PMID 27334521, PMID 29065098, PMID 30510439
2009 (1), 2014 (1)